Search results
Novo Nordisk braces for challenge to Ozempic and Wegovy from wave of generics in China
Reuters via Yahoo Finance· 3 weeks agoSHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising...
Second Chinese drugmaker seeks approval for Ozempic generic
Reuters via AOL· 2 weeks agoA second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's...
China's CanSino in mRNA vaccine deal with AstraZeneca
Reuters via Yahoo News· 11 months agoSHANGHAI (Reuters) -CanSino Biologics has agreed with AstraZeneca to provide "contract development...
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters via Yahoo News· 8 months agoChinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning...
Moderna inks deal to make mRNA medicines in China
CNN Business via Yahoo Finance· 12 months agoUS drugmaker Moderna has signed a deal to make mRNA medicines in China as part of its first major investment in the country, despite escalating trade and...
GSK signs shingles vaccine deal with China's Zhifei for around $3 billion
Reuters via Yahoo News· 9 months agoChina's largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds ($3.05...
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists
Reuters via Yahoo News· 3 weeks agoEmployees of drugmaker WuXi AppTec, under U.S. scrutiny for its links to the Chinese military,...
China drugmakers axe IPO plans as they face scrutiny in anti-graft drive
Reuters via Yahoo Finance· 10 months agoA growing number of healthcare companies in China are shelving their initial public offering (IPO)...
China's Fosun offers to buy out Henlius Biotech, valuing drugmaker at $1.71 billion
Reuters via AOL· 22 hours agoFosun International is one of the country's biggest listed conglomerates, with a portfolio of diverse set of companies, carrying out operations from retail to real-estate. It has been recently ...
AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions
Benzinga via Yahoo Finance· 1 year agoEuropean drugmaker AstraZeneca plc (NASDAQ: AZN) is reportedly drafting a plan to spin off its China...